wada aod9604 prohibited status 2025 The World Anti-Doping Agency (WADA) List: Summary of Changes — Weightlifting Wales Today, we shared new data

AOD 9604 is a synthetic peptide fragment derived from human growth hormone, designed to promote fat breakdown without affecting growth or blood sugar levels

Yes, research peptides such as AOD9604 5 mg are endotoxin tested to meet laboratory standards, supporting reproducibility and consistency in controlled research environments

Most injection-related non-response stems from intramuscular rather than subcutaneous administration, which alters absorption kinetics unpredictably.

Hematocrit and reticulocyte counts should be repeated daily from the fifth to seventh days of therapy, and then frequently until the hematocrit is normal